[two_third]Please refer to the Nano4Life 2012 Conference presentation from Atelix.
Disease-specific nanotechnologies for tomorrow, continue to advance, despite restricted access to finance and the impacts of other macro-economic factors faced by today’s healthcare providers. The presentation addresses the critical success factors that shape healthcare nanotechnology platforms for commercial partnering as the on-going investments establish clinical proof-of-concept and technology validation.
[/two_third] [one_third_last][clear][gview file=”https://atelix.test/wp-content/uploads/2013/02/Nano4Life-2012-Biopharma-Partnering-Needs-1.pdf” height=”200px” width=”150px”][/one_third_last]
Do send us your views on healthcare nano-tech commercialisation to email@example.com– we’ll be happy to channel these to the commercial “movers-and-shakers” within the Atelix nano-tech network.